Latest News Archive

Please select Category, Year, and then Month to display items

Dr William Mhundwa first UFS graduate to receive prestigious Suzman Medal

07 March 2023 | Story André Damons | Photo Reuben Maeko

Dr William Mhundwa, Senior Registrar in the Department of Internal Medicine at the University of the Free State (UFS), has become the first candidate from the institution to be awarded the prestigious Suzman Medal as the top student in the 2022 examinations of the Fellowship of the College of Physicians (FCP).

Candidates from all medical schools in the country as well as other African countries wrote this examination in January and July 2022. Dr Mhundwa came out on top and was awarded the medal by the Senate of the Colleges of Medicine of South Africa (CMSA), which oversees the examinations.

“I congratulate Dr Mhundwa on his outstanding performance,” commented Prof Nicholas Pearce, Head of the School: Clinical Medicine at the UFS. According to him, this is a prestigious award, and given that it is the first time that a candidate from this university has been awarded this medal, it is extra special for us as a department, faculty, and institution.

Dr Mhundwa was born in Harare, Zimbabwe, to subsistence farmers and is the eldest of four boys. He immigrated to South Africa nearly ten years ago and started studying medicine as a way to fulfil his parents’ dreams. He eventually found his calling in internal medicine, specifically nephrology (kidney disease), and would like to obtain further qualifications in this field at the university.

“My achievements are the result of dedication to teaching internal medicine consultants. I am indebted to the Free State Department of Health for the opportunity to train and work under them. I hope to see great academic achievements within this province,” says Dr Mhundwa.

He will graduate in April 2023 with a Master of Medicine, cum laude. His thesis was about The Prevalence of Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients in Central South Africa.

Dr Mhundwa believes “that kidney disease is a scourge in modern society. Early diagnosis is necessary to prevent patients from requiring kidney transplants and dialysis and to improve the quality of life of my patients”.

Prof Thabiso Mofokeng, Head of Department: Internal Medicine, said, “This achievement represents the UFS’ high academic standards on national front. We hope this is the first of many.”

News Archive

Researchers receive study grant for research into Congo Fever

2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept